Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hyperglycemia"" wg kryterium: Temat


Starter badań:

Tytuł:
Nonketotic hyperglycemia hemichorea and hemiballismus: a case report.
Autorzy:
Dixit A; Department of Neurology, Institute of Medical Science, Banaras Hindu University, Varanasi, India. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Mar 12; Vol. 18 (1), pp. 154. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Chorea*/drug therapy
Chorea*/etiology
Diabetes Mellitus, Type 2*/complications
Dyskinesias*/etiology
Dyskinesias*/complications
Hyperglycemia*/complications
Hyperglycemia*/drug therapy
Movement Disorders*/complications
Autoimmune Diseases*
Humans ; Female ; Middle Aged ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł:
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease.
Autorzy:
Wang L; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.; Department of Cardiology, Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Wang C; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Lang JC; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Xu RD; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Cong HL; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China. .
Zhang JX; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China. .
Hu YC; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Li TT; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Liu CW; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Yang H; Department of Cardiology, Tianjin Chest Hospital, Tianjin University, 261 Tai'erzhuang Road, Jinnan District, Tianjin, 300222, China.
Li WY
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 11; Vol. 23 (1), pp. 93. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Coronary Artery Disease*/diagnostic imaging
Diabetes Mellitus*
Hyperglycemia*/complications
Hyperglycemia*/diagnosis
Humans ; Natriuretic Peptide, Brain ; Prognosis ; Biomarkers ; Peptide Fragments
Czasopismo naukowe
Tytuł:
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer.
Autorzy:
Rodón J; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. .
Demanse D; Early Development Biostatistics, Novartis Pharma AG, Basel, Switzerland.
Rugo HS; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Burris HA; Department of Oncology, Sarah Cannon Research Institute, Tennessee Oncology Professional Limited Liability Corporation, Nashville, TN, USA.
Simó R; Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Barcelona, Spain.; Department of Medicine and Endocrinology, Autonomous University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain.
Farooki A; Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wellons MF; Vanderbilt University Medicine Center, Nashville, TN, USA.
André F; Department of Medical Oncology, INSERM U981, Gustave Roussy, Université Paris-Sud, Villejuif, France.
Hu H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Vuina D; Novartis Pharma AG, Basel, Switzerland.
Quadt C; Translational Clinical Oncology, Novartis Pharma AG, Basel, Switzerland.
Juric D; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Pokaż więcej
Źródło:
Breast cancer research : BCR [Breast Cancer Res] 2024 Mar 04; Vol. 26 (1), pp. 36. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Hyperglycemia*/chemically induced
Hyperglycemia*/epidemiology
Thiazoles*
Humans ; Female ; Fulvestrant/adverse effects ; Risk Assessment
Czasopismo naukowe
Tytuł:
TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Autorzy:
Liu C; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Zheng Y; Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
Hu S; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Liang X; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Li Y; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Yu Z; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Liu Y; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Bian Y; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China.
Man Y; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China.
Zhao S; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China.
Liu X; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China.
Liu H; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China.
Huang T; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China.
Ma J; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China.
Chen ZJ; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China; Research Unit of Gametogenesis and Health of ART-Offspring, Chinese Academy of Medical Sciences (No.2021RU001), Jinan, Shandong 250012, China; Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai 200135, China; Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200135, China. Electronic address: .
Zhao H; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China. Electronic address: .
Zhang Y; State Key Laboratory of Reproductive Medicine and Offspring Health, Shandong University, Jinan, Shandong 250012, China; Center for Reproductive Medicine, Shandong University, Jinan, Shandong 250012, China; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, Shandong 250012, China; Shandong Key Laboratory of Reproductive Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250012, China; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, Shandong 250012, China. Electronic address: zhang_.
Pokaż więcej
Źródło:
Metabolism: clinical and experimental [Metabolism] 2024 Mar; Vol. 152, pp. 155766. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Experimental*/metabolism
Diabetes Mellitus, Type 2*/genetics
Diabetes Mellitus, Type 2*/metabolism
Hyperglycemia*/genetics
Hyperglycemia*/metabolism
Insulin Resistance*
Animals ; Humans ; Mice ; Forkhead Box Protein O1/genetics ; Forkhead Box Protein O1/metabolism ; Gluconeogenesis/genetics ; Glucose/metabolism ; Liver/metabolism ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
A fetal rat model of ventricular noncompaction caused by intrauterine hyperglycemia.
Autorzy:
Wang F; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
Han S; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
Fang L; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
Lin X; Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China. Electronic address: .
Pokaż więcej
Źródło:
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology [Cardiovasc Pathol] 2024 Mar-Apr; Vol. 69, pp. 107601. Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Ventricles*
Hyperglycemia*/complications
Hyperglycemia*/pathology
Pregnancy ; Rats ; Animals ; Female ; Rats, Sprague-Dawley ; Myocardium/pathology ; Tretinoin
Czasopismo naukowe
Tytuł:
Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
Autorzy:
Gupta M; Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India.
Rumman M; Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, India.
Singh B; Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India.
Mahdi AA; Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India.
Pandey S; Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India. .
Pokaż więcej
Źródło:
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Mar; Vol. 397 (3), pp. 1647-1658. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Berberine*/pharmacology
Berberine*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Experimental*/chemically induced
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Mice ; Animals ; Glucocorticoids/pharmacology ; Glucocorticoids/therapeutic use ; Glucose/metabolism ; Anti-Inflammatory Agents/therapeutic use ; Obesity/drug therapy
Czasopismo naukowe
Tytuł:
The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005-2018.
Autorzy:
Ding L; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China.
Zhang H; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China.
Dai C; Department of Health Policy and Management, School of Public Health, Peking University Health Science Center, Beijing, 100191, China.
Zhang A; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China.
Yu F; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China.
Mi L; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China.
Qi Y; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China.
Tang M; Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, No.167 Beilishi Rd, Xicheng District, Beijing, 100037, China. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 28; Vol. 23 (1), pp. 84. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prediabetic State*/epidemiology
Diabetes Mellitus*/epidemiology
Hyperglycemia*/diagnosis
Hyperglycemia*/complications
Cardiovascular Diseases*/epidemiology
Humans ; Nutrition Surveys ; Prognosis
Czasopismo naukowe
Tytuł:
Detoxification of Hyperglycemia-induced Glucose Toxicity by the Hexosamine Biosynthetic Pathway.
Autorzy:
Wang AJ; School of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Wang A; Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Hascall V; Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Pokaż więcej
Źródło:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2024 Feb 21; Vol. 29 (2), pp. 71.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetic Nephropathies*/complications
Hyperglycemia*/complications
Hyperglycemia*/metabolism
Humans ; Glucose/metabolism ; Biosynthetic Pathways ; Hexosamines
Czasopismo naukowe
Tytuł:
[Non-Insulin Antidiabetic Agents in the Management of Hyperglycaemia of Non-Critical Hospitalized Patients].
Autorzy:
Monteiro Lopes S; Grupo de Estudos de Diabetes. Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Lisboa; Serviço de Endocrinologia, Diabetes e Metabolismo. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
Maia A; Grupo de Estudos de Diabetes. Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Lisboa; Serviço de Endocrinologia. Centro Hospitalar Universitário do Porto. Porto. Portugal.
Melo P; Grupo de Estudos de Diabetes. Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Lisboa; Serviço de Endocrinologia. Unidade Local de Saúde de Matosinhos. Portugal.
Abreu S; Grupo de Estudos de Diabetes. Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Lisboa; Serviço Regional de Saúde da Região Autónoma da Madeira. Funchal. Portugal.
Paiva I; Grupo de Estudos de Diabetes. Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Lisboa; Serviço de Endocrinologia, Diabetes e Metabolismo. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
Barros L; Grupo de Estudos de Diabetes. Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Lisboa; Serviço de Endocrinologia, Diabetes e Metabolismo. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.
Pokaż więcej
Transliterated Title:
Antidiabéticos Não Insulínicos na Abordagem da Hiperglicemia nos Doentes Hospitalizados por Doença Aguda Não Crítica.
Źródło:
Acta medica portuguesa [Acta Med Port] 2024 Feb 05; Vol. 37 (3), pp. 207-214. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
English Abstract; Journal Article; Review
MeSH Terms:
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Adult ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin/therapeutic use ; Acute Disease
Czasopismo naukowe
Tytuł:
Safety of non-standard regimen of systemic steroid therapy in patients with Graves' orbitopathy: a single-centre experience.
Autorzy:
Sawicka-Gutaj N; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland. .
Gruszczyński D; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland.
Zawalna N; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland.
Nijakowski K; Department of Conservative Dentistry and Endodontics, Poznań University of Medical Sciences, Poznań, Poland.
Skiba A; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland.
Pochylski M; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland.
Sowiński J; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland.
Ruchała M; Department of Endocrinology, Metabolic Disorders and Internal Medicine, Poznań University of Medical Sciences, 49 Przybyszewskiego Street, 60-355, Poznań, Poland.
Pokaż więcej
Źródło:
Pharmacological reports : PR [Pharmacol Rep] 2024 Feb; Vol. 76 (1), pp. 185-194. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Graves Ophthalmopathy*/drug therapy
Graves Ophthalmopathy*/etiology
Graves Disease*/complications
Graves Disease*/drug therapy
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Humans ; Female ; Retrospective Studies ; Glucocorticoids/adverse effects ; Methylprednisolone/adverse effects ; Transaminases
Czasopismo naukowe
Tytuł:
Relationship between stress hyperglycemia ratio and acute kidney injury in patients with congestive heart failure.
Autorzy:
Li L; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China.
Ding L; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China.
Zheng L; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China.
Wu L; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China.
Hu Z; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China.
Liu L; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China.
Yao Y; Peking Union Medical College, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, 100037, China. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jan 13; Vol. 23 (1), pp. 29. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperglycemia*/diagnosis
Hyperglycemia*/epidemiology
Hyperglycemia*/complications
Acute Kidney Injury*/diagnosis
Acute Kidney Injury*/epidemiology
Acute Kidney Injury*/etiology
Heart Failure*/diagnosis
Heart Failure*/epidemiology
Heart Failure*/complications
Humans ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Association between stress hyperglycemia ratio and prognosis in acute ischemic stroke: a systematic review and meta-analysis.
Autorzy:
Jiang Z; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Wang K; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Duan H; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Du H; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Gao S; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Chen J; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Fang S; Department of Neurology, Neuroscience Centre, the First Hospital of Jilin University, Changchun, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Jan 02; Vol. 24 (1), pp. 13. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Ischemic Stroke*
Brain Ischemia*
Hyperglycemia*
Stroke*/therapy
Humans ; Prognosis
Czasopismo naukowe
Tytuł:
U-shaped association between stress hyperglycemia ratio and risk of all-cause mortality in cardiac ICU.
Autorzy:
Li L; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Ding L; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Zheng L; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Wu L; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Hu Z; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Liu L; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Zhang Z; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Zhou L; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China.
Yao Y; Chinese Academy of Medical Sciences, Peking Union Medical College, National Center for Cardiovascular Diseases, Fuwai Hospital, Beijing, China. Electronic address: .
Pokaż więcej
Źródło:
Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2024 Jan; Vol. 18 (1), pp. 102932. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperglycemia*/etiology
Humans ; Retrospective Studies ; Blood Glucose/analysis ; Intensive Care Units ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł:
Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition.
Autorzy:
Weintraub MA; New York University Diabetes & Endocrine Associates, 222 East 41st Street, 23rd Floor, New York, NY, 10017, USA.
Liu D; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
DeMatteo R; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Goncalves MD; Goncalves Lab, Weill Cornell Medicine, 413 East 69th Street, New York, NY, 10021, USA.
Flory JH; Endocrinology Service, Division of Subspecialty Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. .
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jan; Vol. 203 (1), pp. 85-93. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Breast Neoplasms*/drug therapy
Diabetic Ketoacidosis*/chemically induced
Diabetic Ketoacidosis*/drug therapy
Diabetic Ketoacidosis*/epidemiology
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Adult ; Humans ; Female ; Phosphatidylinositol 3-Kinases ; Phosphatidylinositol 3-Kinase ; Hypoglycemic Agents ; Blood Glucose ; Sodium
Czasopismo naukowe
Tytuł:
A case of rapidly declining glycemic control and diabetic ketoacidosis in a newly diagnosed diabetes patient after starting teprotumumab for thyroid eye disease.
Autorzy:
Carter C; Atrium Health Wake Forest Baptist (Pharmacy), Winston-Salem, NC, USA. .
Marks M; Atrium Health Carolinas Medical Center (Pharmacy), Charlotte, NC, USA.
Bundeff AW; Atrium Health Wake Forest Baptist (Pharmacy), Winston-Salem, NC, USA.
Adewodu T; Atrium Health Wake Forest Baptist (Pharmacy), Winston-Salem, NC, USA.
Alderman L; Atrium Health Wake Forest Baptist (Pharmacy), Winston-Salem, NC, USA.
Pokaż więcej
Źródło:
Endocrine [Endocrine] 2024 Jan; Vol. 83 (1), pp. 65-68. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Diabetic Ketoacidosis*/chemically induced
Diabetic Ketoacidosis*/drug therapy
Graves Ophthalmopathy*/drug therapy
Graves Ophthalmopathy*/complications
Hyperglycemia*/chemically induced
Hyperglycemia*/complications
Diabetes Mellitus*
Antibodies, Monoclonal, Humanized*
Humans ; Glycated Hemoglobin ; Glycemic Control/adverse effects ; Glucose
Czasopismo naukowe
Tytuł:
Intensive Care Unit Hyperglycemia After Cardiac Surgery: Risk Factors and Clinical Outcomes.
Autorzy:
Kourek C; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Georgopoulou M; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Kolovou K; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Rouvali N; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Panoutsopoulou M; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Kinti C; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Soulele T; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Doubou D; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Karanikas S; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Elaiopoulos D; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Karabinis A; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece.
Dimopoulos S; Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece. Electronic address: .
Pokaż więcej
Źródło:
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2024 Jan; Vol. 38 (1), pp. 162-169. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Hyperglycemia*/diagnosis
Hyperglycemia*/epidemiology
Hyperglycemia*/etiology
Cardiac Surgical Procedures*/adverse effects
Acute Kidney Injury*/etiology
Humans ; Blood Glucose ; Prospective Studies ; Intensive Care Units ; Risk Factors ; Glucose ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.
Autorzy:
Hasan IH; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11459, Saudi Arabia.. Electronic address: .
Shaheen SY; Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Alhusaini AM; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11459, Saudi Arabia.
Mahmoud AM; Department of Life Sciences, Faculty of Science & Engineering, Manchester Metropolitan University, Manchester M1 5GD, UK.. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2024 Mar 01; Vol. 340, pp. 122445. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/metabolism
Diabetes Mellitus, Experimental*/complications
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/metabolism
Hyperglycemia*/metabolism
Rats ; Animals ; NF-E2-Related Factor 2/metabolism ; Kelch-Like ECH-Associated Protein 1/metabolism ; Caspase 3/metabolism ; NF-kappa B/metabolism ; Simvastatin/pharmacology ; Simvastatin/therapeutic use ; Kidney/metabolism ; Oxidative Stress ; Antioxidants/pharmacology ; Antioxidants/metabolism ; Inflammation/pathology ; Fibrosis
Czasopismo naukowe
Tytuł:
Hyperglycemia modulates M1/M2 macrophage polarization in chronic diabetic patients with pulmonary tuberculosis infection.
Autorzy:
Panda S; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi -110029, India.
Arora A; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi -110029, India.
Luthra K; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi -110029, India.
Mohan A; Department of Pulmonary Medicine, All India Institute of Medical Sciences, New Delhi -110029, India.
Vikram NK; Department of Medicine, All India Institute of Medical Sciences, New Delhi -110029, India.
Kumar Gupta N; Department of Pulmonary Medicine, VMMC and Safdarjung Hospital, New Delhi -110029, India.
Singh A; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi -110029, India. Electronic address: .
Pokaż więcej
Źródło:
Immunobiology [Immunobiology] 2024 Mar; Vol. 229 (2), pp. 152787. Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Hyperglycemia*
Tuberculosis, Pulmonary*/complications
Humans ; Glycated Hemoglobin ; Macrophages ; Cytokines ; Interferon-gamma/genetics
Czasopismo naukowe
Tytuł:
Natural diterpenoid EKO activates deubiqutinase ATXN3 to preserve vascular endothelial integrity and alleviate diabetic retinopathy through c-fos/focal adhesion axis.
Autorzy:
Ge D; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Luo T; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Sun Y; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Liu M; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Lyu Y; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Yin W; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Li R; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Zhang Y; School of Biological Science and Technology, University of Jinan, Jinan 250024, China.
Yue H; Department of Emergency Medicine, Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital, Shandong University, Jinan, China. Electronic address: .
Liu N; School of Biological Science and Technology, University of Jinan, Jinan 250024, China. Electronic address: mls_.
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2024 Mar; Vol. 260 (Pt 2), pp. 129341. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Retinopathy*/drug therapy
Diabetic Retinopathy*/metabolism
Diabetes Mellitus, Experimental*/metabolism
Hyperglycemia*/drug therapy
Hyperglycemia*/metabolism
Epoxy Resins*
Mice ; Animals ; Endothelium, Vascular ; Vinculin ; Focal Adhesions ; Proto-Oncogene Proteins c-fos ; Cell Adhesion Molecules/metabolism ; Glucose/metabolism
Czasopismo naukowe
Tytuł:
Development of a requirement for exogenous insulin treatment in dogs with hyperglycemia.
Autorzy:
DiNinni A; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hess RS; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Journal of veterinary internal medicine [J Vet Intern Med] 2024 Mar-Apr; Vol. 38 (2), pp. 980-986. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperglycemia*/drug therapy
Hyperglycemia*/veterinary
Diabetes Mellitus, Type 2*/veterinary
Dog Diseases*/drug therapy
Humans ; Dogs ; Animals ; Retrospective Studies ; Longitudinal Studies ; Insulin/therapeutic use ; Blood Glucose
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies